Australian lawmakers are anticipated to approve landmark legislation in the coming months allowing for the production and use of cannabis for therapeutic purposes.
The legislation, which is backed by Australia’s Prime Minister, Health Minister, and leading political parties, amends national drug laws to permit for the licensed cultivation and distribution of medicinal cannabis.
The move by Parliament follows recent efforts by several Australian territories to provide patients participating in clinical trials with access to the plant.
“This government understands that there are some Australians suffering from severe conditions for which cannabis may have applications,” Health Minister Sussan Ley told Parliament this week. “[W]e want to enable access to the most effective medical treatments available.”
She added, “Allowing controlled cultivation locally will provide the critical missing piece for a sustainable legal supply of safe medicinal cannabis products for Australian patients in the future.”
To date, only Canada, Israel, and the Netherlands federally license private growers to provide medical marijuana to qualified patients. Colombia, Jamaica, and Puerto Rico are also expected to begin licensing medical marijuana manufacturing in the near future.
In 2013, Uruguay officials approved legislation authorizing the retail production and sale of cannabis to those age 18 and older. Consumers in that country are anticipated to be able to begin purchasing cannabis at state-licensed pharmacies by mid-2016.